REFERENCES
- Smith D J. The pharmacokinetics, metabolism, and tissue residues of beta-adrenergic agonists in livestock. J Anim Sci 1998; 76: 173–194
- Martinez-Navarro J F. Food poisoning related to consumption of illicit β-agonist in liver. Lancet 1990; 336: 1311
- Pulce C, Lamaison D, Keck G, et al. Collective human food poisonings by clenbuterol residues in veal liver. Vet Hum Toxicol 1991; 33: 480–481
- Foodborne clenbuterol poisoning. Wkly Epidemiol Rec 1992; 67: 279–280
- Slivano M, Edoarda C, Roberto A, et al. β-blockers to prevent clenbuterol poisoning. Lancet 1995; 346: 180
- Salleras L, Dominguez A, Mata E, et al. Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain. Public Health Rep 1995; 110: 338–342
- Bilbao G J, Hoyo JJ F, Lopez J M, et al. Clenbuterol poisoning Clinical and analytical data on an outbreak in Mostoles, Madrid. Rev Clin Esp 1997; 197: 92–95
- Gianfranco B, Loizzo A, Fontana L, et al. Food poisoning following consumption of clenbuterol-treated veal in Italy. JAMA 1997; 278: 635
- Sporano V, Grasso L, Esposito M, et al. Clenbuterol residues in non-liver containing meat as a cause of collective food poisoning. Vet Hum Toxicol 1998; 40: 141–143
- Chan TY K. Food poisoning following the consumption of clenbuterol-treated livestock. HK Pract 1998; 20: 366–369
- Hans-Peter E. Drug evaluations: Clenbuterol. Colorado: Micromedex 1997
- Meyer H H, Rinke L M. The pharmacokinetics and residues of clenbuterol in veal calves. J Anim Sci 1991; 69: 4538–4544
- Smith D J, Paulson G D. Distribution, elimination, and residues of [14C] clenbuterol HCl in Holstein calves. J Anim Sci 1997; 75: 454–461
- Kuiper H A, Noordam M Y, van Dooren-Flipsen M M, Schilt R, Roos A H. Illegal use of beta-adrenergic agonists: European Community. J Anim Sci 1998; 76: 195–207
- Spangler D L. Review of side effects associated with beta agonists. Ann Allergy 1989; 62: 59–62
- Suissa S, Hemmelgarn B, Blais L, Ernst P. Bronchodilators and acute cardiac death. Am J Respir Crit Care Med 1996; 154: 1598–1602
- Cazzola M, Imperatore F, Salzillo A, et al. Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia. Chest 1998; 114: 411–415
- Wong K, Boheler K R, Bishop J, Petrou M, Yacoub M H. Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features. Cardiovasc Res 1998; 37: 115–122
- Cubria J C, Reguera R, Balana-Fouce R, Ordonez C, Ordonez D. Polyamine-mediated hypertrophy induced by clenbuterol in the mouse. J Pharm Pharmacol 1998; 50: 91–96
- Goldstein D R, Dobbs T, Krull B, Plumb V J. Clenbuterol and anabolic steroids: Previously unreported cause of myocardial infarction with normal coronary arteriograms. South Med J 1998; 91: 780–784
- Rose N DI, Shearer G, Farrington W H. The effect of cooking on veterinary drug residues in food: 1. Clenbuterol. Food Addit Contam 1995; 12: 67–76
- Gaillard Y, Balland A, Doucet F, Pepin G. Detection of illegal clenbuterol use in calves using hair analysis. Application in meat quality control. J Chromatogr B Biomed Sci Appl 1997; 703: 85–95